Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes

Guardado en:
Detalles Bibliográficos
Autores principales: Kazuhiro Kakimi, Hirokazu Matsushita, Masaaki Komatsu, Eiryo Kawakami, Mikako Nishida, Nahoko Yamashita, Taisaku Ogawa, Keita Koseki, Eiji Warabi, Tomoyuki Ohue, Katsuyuki Shiroguchi, Heiichiro Udono
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/ea6e95b1875f4efea28894d8d086bffc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea6e95b1875f4efea28894d8d086bffc
record_format dspace
spelling oai:doaj.org-article:ea6e95b1875f4efea28894d8d086bffc2021-11-12T12:30:05ZMitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes10.1136/jitc-2021-0029542051-1426https://doaj.org/article/ea6e95b1875f4efea28894d8d086bffc2021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e002954.fullhttps://doaj.org/toc/2051-1426Kazuhiro KakimiHirokazu MatsushitaMasaaki KomatsuEiryo KawakamiMikako NishidaNahoko YamashitaTaisaku OgawaKeita KosekiEiji WarabiTomoyuki OhueKatsuyuki ShiroguchiHeiichiro UdonoBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Kazuhiro Kakimi
Hirokazu Matsushita
Masaaki Komatsu
Eiryo Kawakami
Mikako Nishida
Nahoko Yamashita
Taisaku Ogawa
Keita Koseki
Eiji Warabi
Tomoyuki Ohue
Katsuyuki Shiroguchi
Heiichiro Udono
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
format article
author Kazuhiro Kakimi
Hirokazu Matsushita
Masaaki Komatsu
Eiryo Kawakami
Mikako Nishida
Nahoko Yamashita
Taisaku Ogawa
Keita Koseki
Eiji Warabi
Tomoyuki Ohue
Katsuyuki Shiroguchi
Heiichiro Udono
author_facet Kazuhiro Kakimi
Hirokazu Matsushita
Masaaki Komatsu
Eiryo Kawakami
Mikako Nishida
Nahoko Yamashita
Taisaku Ogawa
Keita Koseki
Eiji Warabi
Tomoyuki Ohue
Katsuyuki Shiroguchi
Heiichiro Udono
author_sort Kazuhiro Kakimi
title Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
title_short Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
title_full Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
title_fullStr Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
title_full_unstemmed Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
title_sort mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of nrf2/mtorc1/p62 axis in tumor-infiltrating cd8t lymphocytes
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/ea6e95b1875f4efea28894d8d086bffc
work_keys_str_mv AT kazuhirokakimi mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT hirokazumatsushita mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT masaakikomatsu mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT eiryokawakami mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT mikakonishida mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT nahokoyamashita mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT taisakuogawa mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT keitakoseki mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT eijiwarabi mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT tomoyukiohue mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT katsuyukishiroguchi mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
AT heiichiroudono mitochondrialreactiveoxygenspeciestriggermetformindependentantitumorimmunityviaactivationofnrf2mtorc1p62axisintumorinfiltratingcd8tlymphocytes
_version_ 1718430531916398592